NCT05559359 · Interventional trial
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Overall registry status Active not recruiting
Phase 3
Conditions Atopic Dermatitis, Eczema
Delaware Valley sites
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory